Publication	Data		Fish	Anatomy
Wang et al., 2022	Fig. 1		ppargecn6/ecn6 (AB)	female organism intestine pparg expression decreased amount, abnormal female organism liver pparg expression decreased amount, abnormal female organism liver Ab4-pparg labeling decreased amount, abnormal female organism muscle pparg expression decreased amount, abnormal female organism ovary pparg expression decreased amount, abnormal female organism pleuroperitoneal region pparg expression decreased amount, abnormal female organism pleuroperitoneal region Ab4-pparg labeling decreased amount, abnormal female organism visceral fat decreased amount, abnormal male organism intestine pparg expression decreased amount, abnormal male organism liver pparg expression decreased amount, abnormal male organism liver Ab4-pparg labeling decreased amount, abnormal male organism muscle pparg expression decreased amount, abnormal male organism pleuroperitoneal region pparg expression decreased amount, abnormal male organism pleuroperitoneal region Ab4-pparg labeling decreased amount, abnormal male organism testis pparg expression decreased amount, abnormal visceral fat decreased amount, abnormal
	Fig. 2		ppargecn6/ecn6 (AB)	female organism aerobic respiration decreased rate, abnormal female organism cholesterol decreased amount, abnormal female organism fatty acid increased amount, abnormal female organism lipase activity increased occurrence, abnormal female organism triglyceride decreased amount, abnormal liver triglyceride decreased amount, abnormal whole organism decreased weight, abnormal
	Fig. 3		ppargecn6/ecn6 (AB)	female organism atf6 expression increased amount, abnormal female organism casp9 expression increased amount, abnormal female organism cat expression decreased amount, abnormal female organism ddit3 expression increased amount, abnormal female organism hspa5 expression increased amount, abnormal female organism nfe2l2a expression decreased amount, abnormal female organism sod1 expression decreased amount, abnormal female organism liver composition, abnormal female organism reactive oxygen species increased amount, abnormal female organism superoxide dismutase activity decreased occurrence, abnormal liver malonaldehyde increased amount, abnormal liver reactive oxygen species increased amount, abnormal liver superoxide dismutase activity decreased occurrence, abnormal
	Fig. 5		ppargecn6/ecn6 (AB)	female organism atf6 expression increased amount, abnormal female organism casp9 expression increased amount, abnormal female organism ddit3 expression increased amount, abnormal female organism hspa5 expression increased amount, abnormal female organism nfkb2 expression increased amount, abnormal female organism decreased weight, abnormal female organism liver composition, abnormal liver fatty acid increased amount, abnormal liver malonaldehyde increased amount, abnormal liver triglyceride decreased amount, abnormal
	Fig. 6		ppargecn6/ecn6 (AB)	female organism acaca expression decreased amount, abnormal female organism atf6 expression increased amount, abnormal female organism bcl2a expression decreased amount, abnormal female organism casp9 expression increased amount, abnormal female organism cat expression decreased amount, abnormal female organism ddit3 expression increased amount, abnormal female organism dgat2 expression decreased amount, abnormal female organism fasn expression decreased amount, abnormal female organism gpx1a expression decreased amount, abnormal female organism hspa5 expression increased amount, abnormal female organism il1b expression increased amount, abnormal female organism nfe2l2a expression decreased amount, abnormal female organism nfkb2 expression increased amount, abnormal female organism pnpla2 expression increased amount, abnormal female organism pparg expression decreased amount, abnormal female organism liver composition, abnormal liver fatty acid increased amount, abnormal liver malonaldehyde increased amount, abnormal liver reactive oxygen species increased amount, abnormal liver triglyceride decreased amount, abnormal
Zhao et al., 2022	Fig. 1		ppargzf3729/zf3729 (AB)	liver pparg expression decreased amount, abnormal liver lysophosphatidylcholine increased amount, abnormal liver monoacylglycerol increased amount, abnormal liver phosphatidylcholine increased amount, abnormal male organism hepatocyte congested, abnormal male organism hepatocyte transparent, abnormal
	Fig. 2		ppargzf3729/zf3729 (AB)	liver lipid droplet decreased amount, abnormal liver triglyceride decreased amount, abnormal liver vacuole decreased amount, abnormal
Cheng et al., 2019	Figure 2		WT + MO3-pparg	heart edematous, abnormal heart looping process quality, abnormal whole organism ventralized, abnormal
	Figure 4		WT + MO3-pparg	embryo development ending in birth or egg hatching delayed, abnormal whole organism decreased life span, abnormal whole organism ventralized, abnormal
Carter et al., 2017	Fig. 1		ppargwi701/wi701	fin pparg expression decreased amount, abnormal
O'Hare et al., 2016	Fig. 1		jh1Tg; jh2Tg + MO2-pparg	pancreatic B cell increased area, abnormal
	Fig. 2		jh1Tg; jh2Tg + MO2-pparg	pancreatic B cell increased amount, abnormal
	Fig. S11		nl1Tg + MO2-pparg	endocrine pancreas EGFP expression increased distribution, abnormal
	Fig. S3		jh1Tg; jh2Tg + MO2-pparg	pancreatic B cell mCherry expression increased distribution, abnormal